Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05446909 · ClinicalTrials.gov registry record · NA

Preventing Cognitive Decline

A NA study of Cognitive Decline, sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05446909 is a NA study of Cognitive Decline that has completed, run by Arizona State University. The registered enrollment target is 40 participants, below the 1,149-participant average among 61 other Cognitive Decline trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05446909, a NA study of Cognitive Decline, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The study aims to understand the mechanisms and training effects of evidence-based body-mind training on improving cognitive performance and preventing cognitive decline.

Conditions Studied

Cognitive Decline

Interventions

  • BEHAVIORAL health education
  • BEHAVIORAL IBMT mindfulness

Study Locations (1)

Arizona

  • Arizona State University - Phoenix

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-02-01
Est. Completion 2023-02-28
Phase NA

Sponsor

Arizona State University

187 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05446909

The ClinicalTrials.gov registry entry for NCT05446909 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,149-participant average among 61 other Cognitive Decline trials with a reported enrollment target (97% lower). The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which health education is the first listed.

NCT05446909 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05446909 about?

NCT05446909 is a clinical study titled "Preventing Cognitive Decline". The study aims to understand the mechanisms and training effects of evidence-based body-mind training on improving cognitive performance and preventing cognitive decline.

What is the current status of trial NCT05446909?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-02-01. Estimated completion is 2023-02-28.

What conditions does trial NCT05446909 study?

This clinical trial studies the following conditions: Cognitive Decline.

What interventions are being tested in trial NCT05446909?

The interventions under investigation include: health education (BEHAVIORAL), IBMT mindfulness (BEHAVIORAL).

Who is sponsoring clinical trial NCT05446909?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05446909 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cognitive Decline

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cognitive Decline

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.